Cargando…
Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers
Breast cancer (BC) is the most common form of cancer among women worldwide. Despite the huge advancements in its treatment, the exact etiology of breast cancer still remains unresolved. There is an increasing interest in the role of the gut microbiome in modulating the anti-cancer therapeutic respon...
Autores principales: | Zidi, Oumaima, Souai, Nessrine, Raies, Henda, Ben Ayed, Farhat, Mezlini, Amel, Mezrioui, Sonia, Tranchida, Fabrice, Sabatier, Jean-Marc, Mosbah, Amor, Cherif, Ameur, Shintu, Laetitia, Kouidhi, Soumaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070723/ https://www.ncbi.nlm.nih.gov/pubmed/33919750 http://dx.doi.org/10.3390/molecules26082266 |
Ejemplares similares
-
High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients
por: Kouidhi, Soumaya, et al.
Publicado: (2021) -
Fecal Metabolomics Reveals Distinct Profiles of Kidney Transplant Recipients and Healthy Controls
por: Kouidhi, Soumaya, et al.
Publicado: (2021) -
Gut microbiota, an emergent target to shape the efficiency of cancer therapy
por: Kouidhi, Soumaya, et al.
Publicado: (2023) -
Multi-Solvent Extraction Procedure for the Pioneer Fecal Metabolomic Analysis—Identification of Potential Biomarkers in Stable Kidney Transplant Patients
por: Kouidhi, Soumaya, et al.
Publicado: (2021) -
Impact of the Post-Transplant Period and Lifestyle Diseases on Human Gut Microbiota in Kidney Graft Recipients
por: Souai, Nessrine, et al.
Publicado: (2020)